Medi-Caps has informed that the window for trading in the shares of the Company shall remain closed from 1st April, 2022 till completion of 48 hours after the declaration of the Audited Standalone and Consolidated Financial Results for the quarter and year ended on 31st March, 2022 to the Stock Exchange. All the Directors, KMP's, Designated Employees, Connected Persons, Fiduciaries and their immediate relatives are advised not to deal in the shares of the Company either directly or indirectly during the aforesaid period. The date of meeting of the Board of Directors to approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended on 31st March, 2022 shall be informed in due course.
The above information is a part of company’s filings submitted to BSE.
